BIFICOL

Welcome to the Brand page for “BIFICOL”, which is offered here for Bacterial and bacteriological preparations for medical or veterinary purposes, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings and to animal livestock species, for medical and veterinary use; bacterial and bacteriological preparations for medical or veterinary purposes, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating diseases of the intestinal bacterial flora; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating intestinal dismicrobic syndromes, caused by diseases that cause changes in the bacterial flora, diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and crohn's disease; pharmaceutical preparations in capsule, compress, solution, suspension, granule, dried granulate or freeze-dried granulate form for use in the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, for use in preventing intestinal inflammation in which inflammation is present on the intestinal wall, and for use in the treatment and prevention of antibiotic associated diarrhea; food supplements; food supplements for medical use containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings, not for medical use; symbiotic supplements containing microorganisms or cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria and prebiotic fibres, symbiotic dietary or nutritional supplements containing microorganisms or cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria and prebiotic fibres;bifid colitis;microorganisms and cultures of micro-organisms in the nature of bacteria, bifidobacteria, yeast and fermented milk products, cultures of microorganisms comprising bacteria, bifidobacteria, or yeast other than for medical or veterinary use, nutrients for use with yeast for industrial use, fermentation extracts and bacteria in the nature of bifidobacteria for use in food manufacture, in food supplements manufacture; fermentation extracts and bacteria for use in food manufacture, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria for administering to human beings and animal livestock species, not for medical or veterinary use; fermentation extracts and bacteria for use in food manufacture, microorganisms and concentrated cultures of probiotic microorganisms in liquid, solid, dried and freeze-dried form for use in food manufacture, in food supplements manufacture;.

Its status is currently believed to be active. Its class is unavailable. “BIFICOL” is believed to be currently owned by “PROBIOTICAL S.P.A.”